Unlock regulatory insights with Watson. Learn More

Reclassification of the Drug Ondansetron (Zofran®) From Pregnancy Risk Category B, to C, D, or X After Consideration of new Safety Information

Docket Item Code P
Center CDER
VIEW ALL (5)Primary Documents
VIEW ALL (4) Comments